PD-L1 expression, rather than PD-L1 amplification, was detected in 16 of the 50 PDX models (32%), of which 18% appeared in both tumor cells and immune cells, 8% appeared only in tumor cells, and 6% appeared only in immune cells (Fig. 2e). This evidence concerns the gene CD274 and neoplasm.